Cardiac Dysautonomia and Serotonin Plasma Levels in Rett Syndrome

Abstract

Background

In Rett syndrome the autonomic nervous system is abnormal at various levels, from the central to the peripheral nervous system. A role for serotoninergic dysfunction has been suggested.

Objectives

The aim of our study was to evaluate the relation between cardiac dysautonomia (expressed by means of heart rate variability) and plasma serotonin levels in girls affected with Rett syndrome. Heart rate variability and plasma serotonin levels were evaluated in 28 Rett girls aged 1 - 14 years. A Pearson correlation was used to determine whether there was a relationship between plasma serotonin levels and each heart rate variability parameter.

Results

In untreated Rett girls the plasma serotonin levels correlated with the sympathovagal balance, as expressed by the low frequency (LF) to high frequency (HF) ratio (p < 0.05).

Conclusions

Our results suggest that cardiac dysautonomia could be linked to serotoninergic dysfunction and that treatment with a serotonin analogue could be useful in improving the sympathovagal balance.

Rett syndrome - dysautonomia - serotonin - sudden death

References

• 1 Amir R E, Van den Veyver I B, Wan M, Tran C Q, Francke U, Zoghbi H Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.  Nat Genet. 1999;  23 185-188
• 2 Armstrong D D. Review of Rett syndrome.  J Neuropathol Exp Neurol. 1997;  56 843-849
• 3 Armstrong D D, Panigrahy A, Sleeper L A, Kinney H C. Preliminary studies demonstrating increased [³H]-lysergic acid diethylamide ([³H]LSD) binding to serotonin receptors in selected nuclei of the brain stem in Rett syndrome (Abstract).  Brain Dev. 1998;  20 324
• 4 Armstrong D D. Rett syndrome neuropathology review 2000.  Brain Dev. 2001;  23 72-76
• 5 Blatt C M, Rabinowitz S H, Lown B. Central serotoninergic agents raise the repetitive extrasystole threshold of the vulnerable period of the canine ventricular myocardium.  Circ Res. 1979;  44 723-730
• 6 Braddock S R, Braddock B A, Graham J M. Rett Syndrome. An update and review for the primary pediatrician.  Clinical Pediatrics. 1993;  32 613-626
• 7 Budden S S, Myer E C, Butler I J. Cerebrospinal fluid studies in the Rett syndrome: Biogenic amines and beta-endorphins.  Brain Dev. 1990;  12 81-84
• 8 Dahlström A. The central and peripheral autonomic nervous system and possible implications in Rett syndrome patients. Kerr A, Witt-Engerström I Rett Disorder and the Developing Brain. Oxford; Oxford University Press 2001: 227-250
• 9 Guideri F, Acampa M, Hayek G, Zappella M, Di Perri T. Reduced heart rate variability in patients affected with Rett syndrome. A possible explanation for sudden death.  Neuropediatrics. 1999;  30 146-148
• 10 Guideri F, Acampa M, Di Perri T, Zappella M, Hayek G. Progressive cardiac dysautonomia observed in patients affected by classic Rett syndrome and not in the preserved speech variant.  J Child Neurol. 2001;  16 370-373
• 11 Julu P O, Kerr A M, Apartopoulos F, Al-Rawas S, Engerström I W, Engerström L. et al . Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder.  Arch Dis Child. 2001;  85 29-37
• 12 Kerr A M, Armstrong D D, Prescott R J, Doyle D, Kearney D. L. Rett syndrome: analysis of deaths in the British survey.  Eur Child Adolesc Psychiatry. 1997;  6 71-74
• 13 Lehnert H, Lobbardi F, Raeder E A, Lorenzo A V, Verrier R L, Lown B. et al . Increased release of brain serotonin reduces vulnerability of ventricular fibrillation in the cat.  J Cardiovasc Pharmacol. 1987;  10 389-397
• 14 Nomura Y, Kimura K, Arai H, Segawa M. Involvement of the autonomic nervous system in the pathophysiology of Rett syndrome.  Eur Child Adolesc Psychiatry. 1997;  6 42-46
• 15 Ramage A G. Central cardiovascular regulation and 5-hydroxytryptamine receptors.  Brain Res Bull. 2001;  56 425-439
• 16 Singer D H, Martin G J, Magid N, Weiss J S, Schaad J W, Kehoe R. et al . Low heart rate variability and sudden cardiac death.  J Electrocardiol. 1988;  21 46-55
• 17 Tagari P C, Boullin D J, Davies C L. Simplified determination of serotonin in plasma by liquid chromatography with electrochemical detection.  Clin Chem. 1984;  30 131-135
• 18 Verrier R. Neurochemical approaches to the prevention of ventricular fibrillation.  Fed Proc. 1986;  45 2191-2196
• 19 Witt-Engerström I, Kerr A. Meeting report. Workshop on autonomic function in Rett syndrome. Swedish Rett Center, Frösön, Sweden, May 1998.  Brain Dev. 1998;  20 323-326
• 20 Zoghbi H Y, Percy A K, Glaze D G, Butler I J, Riccardi V M. Reduction of biogenic amine levels in the Rett syndrome.  N Engl J Med. 1985;  313 921-924